Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 1631 entries
View as:

An Observational Study to Learn More How Chronic Kidney Disease Gradually Changes Over Time in Adults Using Electronic Healthcare Records (CKD Natural History Study)

Phase: N/A Priority: Normal
NCT ID: NCT05914259 Org: User:
Start: 05/31/23 End: 06/15/24 Due: 06/15/25

Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00002238 Org: User:
Start: - End: - Due: -

Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)

Phase: N/A Priority: Normal
NCT ID: NCT04298567 Org: User:
Start: 02/25/22 End: 06/06/24 Due: 06/06/25

Safety Study Comparing Phenylephrine HCL Extended Release Tablets 30 mg and Placebo (Study CL2007-07)(P07529)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00874120 Org: User:
Start: 12/31/08 End: 02/28/09 Due: 02/28/10

A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and Weight

Phase: N/A Priority: Normal
NCT ID: NCT05515432 Org: User:
Start: 08/11/22 End: 06/06/23 Due: 06/06/24

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT02571569 Org: User:
Start: 10/28/15 End: 10/11/18 Due: 10/11/19

Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton

Phase: N/A Priority: Normal
NCT ID: NCT00748046 Org: User:
Start: 08/31/08 End: 10/31/09 Due: 10/31/10

PROmyBETAappGame: a Study to Learn More About the Medication Usage & Patient Reported Outcomes Via the myBETAapp and to Find Out More About the Usage of Game Principles and Game Design Elements (Gamification) in Medical Care of Patients With Multiple Sclerosis Treated With Betaferon

Phase: N/A Priority: Normal
NCT ID: NCT03808142 Org: User:
Start: 02/20/19 End: 09/02/20 Due: 09/02/21

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03517943 Org: User:
Start: 04/24/18 End: 08/30/18 Due: 08/30/19

Sun Protection Factor Assay (316/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02994992 Org: User:
Start: 12/22/16 End: 01/13/17 Due: 01/13/18

Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMD

Phase: N/A Priority: Normal
NCT ID: NCT02321241 Org: User:
Start: 02/01/16 End: 08/18/17 Due: 08/18/18

Study to Learn More About the Onset of Effect of Iberogast in Patients Suffering From Abnormal Stomach and Intestine Function

Phase: N/A Priority: Normal
NCT ID: NCT04059783 Org: User:
Start: 06/17/08 End: 02/20/11 Due: 02/20/12

Evaluation of the Stinging Potential in Human Eyes

Phase: N/A Priority: Normal
NCT ID: NCT02872207 Org: User:
Start: 02/21/15 End: 02/22/15 Due: 02/22/16

Phase III Copanlisib in Rituximab-refractory iNHL

Phase: N/A Priority: Normal
NCT ID: NCT02369016 Org: User:
Start: 09/22/15 End: 10/26/22 Due: 10/26/23

Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) - Assay

Phase: N/A Priority: Normal
NCT ID: NCT02872246 Org: User:
Start: 05/26/15 End: 07/01/15 Due: 07/01/16

Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02823509 Org: User:
Start: 12/10/15 End: 12/14/15 Due: 12/14/16

Survey to Assess Why People Are Not Responding to Treatment in Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01071681 Org: User:
Start: 11/30/09 End: 09/30/10 Due: 09/30/11

A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs

Phase: N/A Priority: Normal
NCT ID: NCT00828971 Org: User:
Start: 11/30/08 End: 10/31/09 Due: 10/31/10

NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes

Phase: N/A Priority: Normal
NCT ID: NCT04945330 Org: User:
Start: 11/05/21 End: 12/31/29 Due: 12/31/30

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01619007 Org: User:
Start: 06/30/12 End: 07/31/15 Due: 07/31/16

Dose Proportionality Study With BAY94-8862 IR (Immediate Release) Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01687920 Org: User:
Start: 09/17/12 End: 03/21/13 Due: 03/21/14

An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)

Phase: N/A Priority: Normal
NCT ID: NCT06315556 Org: User:
Start: 03/05/24 End: 04/30/27 Due: 04/30/28

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05901831 Org: User:
Start: 02/26/24 End: 09/26/25 Due: 09/26/26

Study to Learn More About the Safety of Drug Jivi Over a Long Period of Time in Previously Treated Patients With Hemophilia A (Bleeding Disorder Resulting From a Lack of FVIII) Who Are Receiving Jivi Regularly at Their Treating Doctors to Prevent Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT04461639 Org: User:
Start: 05/14/21 End: 06/30/28 Due: 06/30/29

Sun Protection Factor Assay (319/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02995044 Org: User:
Start: 01/04/17 End: 01/06/17 Due: 01/06/18